# CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice

> **NCT02900248** · — · TERMINATED · sponsor: **CureOne** · enrollment: 23 (actual)

## Conditions studied

- Neoplasms
- Lung Neoplasms
- Colon Neoplasms
- Breast Neoplasms
- Pancreatic Neoplasms
- Prostate Neoplasms
- Kidney Neoplasms
- Liver Neoplasms
- Rectal Neoplasms
- Hematologic Neoplasms
- Multiple Myeloma
- Myelodysplastic Syndromes
- Ovarian Neoplasms
- Bladder Neoplasms
- Testicular Neoplasms
- Endometrial Neoplasms
- Brain Neoplasms
- Biliary Tract Neoplasms
- Head and Neck Neoplasms
- Uterine Cervical Neoplasms
- Skin Neoplasms
- Melanoma
- Gastric Neoplasms
- Anal Neoplasms
- Sarcoma

## Interventions

- **OTHER:** Provider determined

## Key facts

- **NCT ID:** NCT02900248
- **Lead sponsor:** CureOne
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-10-02
- **Primary completion:** 2019-03-29
- **Final completion:** 2019-03-29
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** Registry was built to handle Medicare coverage decision on NGS, but CMS decided to not require data.
- **Last updated:** 2019-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02900248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02900248, "CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT02900248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*